From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Tom Winnifrith Bearcast: it's a small world innit Dave?

By Tom Winnifrith | Wednesday 12 June 2024


Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


I start with sleaze in the small cap world then go to Dispensa (DISP), what I believe happened in light of today's dynamite prospectus fraud expose. This must be dealt with in the most severe fashion. Then it is onto Oracle Power (ORCP), the history of the Northern Zone assets and Big Dave with his daft tweet below. I look at Nightcap (NGHT), its struggling placing 'fess up and rule breaking and at Belluscura (BELL) imagining Adam Reynolds chatting to his auditors in an increasingly panicked fashion. Finally Bluebird Merchant Ventures (BMV), up, up and away.

Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

Sunday »

Quiz

The ShareProphets Sunday Pub Quiz #272

 

AAU

Gold up Ariana down

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

 

APH

Alliance Pharma – a recovery Buy?

Time left: 12:22:04